JP2009531306A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009531306A5 JP2009531306A5 JP2008557733A JP2008557733A JP2009531306A5 JP 2009531306 A5 JP2009531306 A5 JP 2009531306A5 JP 2008557733 A JP2008557733 A JP 2008557733A JP 2008557733 A JP2008557733 A JP 2008557733A JP 2009531306 A5 JP2009531306 A5 JP 2009531306A5
- Authority
- JP
- Japan
- Prior art keywords
- chitosan
- composition
- ascorbic acid
- comprehensive
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 19
- 229920001661 Chitosan Polymers 0.000 claims description 17
- 208000001145 Metabolic Syndrome Diseases 0.000 claims description 13
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims description 13
- 230000002265 prevention Effects 0.000 claims description 12
- 229960005070 ascorbic acid Drugs 0.000 claims description 10
- 235000010323 ascorbic acid Nutrition 0.000 claims description 10
- 239000011668 ascorbic acid Substances 0.000 claims description 10
- 235000015872 dietary supplement Nutrition 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 230000004872 arterial blood pressure Effects 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 4
- 235000002906 tartaric acid Nutrition 0.000 claims 4
- 239000011975 tartaric acid Substances 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 3
- 239000003963 antioxidant agent Substances 0.000 claims 3
- 235000006708 antioxidants Nutrition 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 235000012000 cholesterol Nutrition 0.000 claims 2
- 229940126534 drug product Drugs 0.000 claims 2
- 239000003205 fragrance Substances 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 150000003626 triacylglycerols Chemical class 0.000 claims 2
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2006A000384 | 2006-03-03 | ||
| IT000384A ITMI20060384A1 (it) | 2006-03-03 | 2006-03-03 | Composizioni comprendenti chitosano atte al trattamento terapeutico complessivo o alla prevenzione complessiva della sindrome metabolica |
| PCT/EP2007/052023 WO2007099170A1 (en) | 2006-03-03 | 2007-03-02 | Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009531306A JP2009531306A (ja) | 2009-09-03 |
| JP2009531306A5 true JP2009531306A5 (enExample) | 2013-01-31 |
| JP5557451B2 JP5557451B2 (ja) | 2014-07-23 |
Family
ID=38019452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008557733A Active JP5557451B2 (ja) | 2006-03-03 | 2007-03-02 | メタボリック症候群の包括的な治療的処置又は包括的予防に適した、薬物又は補助食品の形態の、キトサンを有する組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9050356B2 (enExample) |
| EP (1) | EP1996207B1 (enExample) |
| JP (1) | JP5557451B2 (enExample) |
| ES (1) | ES2392551T3 (enExample) |
| IT (1) | ITMI20060384A1 (enExample) |
| MX (1) | MX2008011289A (enExample) |
| PL (1) | PL1996207T3 (enExample) |
| WO (1) | WO2007099170A1 (enExample) |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54148090A (en) * | 1978-05-11 | 1979-11-19 | Ajinomoto Co Inc | Peroral cholesterol-depressant |
| US4223023A (en) | 1978-10-12 | 1980-09-16 | Ivan Furda | Nonabsorbable lipid binder |
| JP2614297B2 (ja) * | 1988-12-27 | 1997-05-28 | 三栄源エフ・エフ・アイ株式会社 | ソーマチンの凝集・分離防止及び甘味改善法 |
| JPH04108734A (ja) * | 1990-08-29 | 1992-04-09 | Kurita Water Ind Ltd | 降コレステロール剤 |
| JP2667351B2 (ja) * | 1992-03-24 | 1997-10-27 | 麒麟麦酒株式会社 | 食餌脂質消化吸収阻害剤および飲食品 |
| JP2507907B2 (ja) * | 1992-06-08 | 1996-06-19 | 水産庁長官 | 血圧降下用の食品添加物質および抗高血圧剤 |
| US5550019A (en) * | 1993-05-26 | 1996-08-27 | La Jolla Cancer Research Foundation | Methods of identifying compounds which alter apoptosis |
| US6180148B1 (en) | 1996-05-28 | 2001-01-30 | Asama Chemical Co., Ltd. | Method for cooking fresh noodles in a microwave oven |
| US20030069206A1 (en) | 1998-07-10 | 2003-04-10 | Nichols Everett J. | Methods and kits for absorbing fat |
| PT1105123E (pt) | 1998-08-14 | 2004-08-31 | Hoffmann La Roche | Composicoes farmaceuticas contendo inibidores da lipase e quitosano |
| JP3371843B2 (ja) | 1999-02-25 | 2003-01-27 | 扶桑化学工業株式会社 | ロングライフ麺およびその製造方法 |
| US20020016307A1 (en) * | 1999-10-27 | 2002-02-07 | Mullins John Jason Gentry | Pharmaceutical composition with both a lipase inhibitor and a lipophilic polysaccharide and an improved method for treating adiposity |
| DE10054450A1 (de) | 2000-09-06 | 2002-03-28 | Guillermo Pasch Alonso | Verfahren zur Modifikation von Getreidemahlerzeugnissen, nach dem Verfahren hergestellte Produkte und deren Verwendung |
| JP5024807B2 (ja) * | 2001-03-21 | 2012-09-12 | 独立行政法人水産総合研究センター | 血圧上昇の抑制組成物 |
| JP2003113089A (ja) * | 2001-10-04 | 2003-04-18 | Gotoo Corporation:Kk | 脂質蓄積性阻害およびコレステロール低下作用を有するキトサン含有製剤および飲食品 |
| JP2003238602A (ja) * | 2002-02-20 | 2003-08-27 | Marino Forum 21 | 血糖値上昇抑制性物質 |
| ITRM20030127A1 (it) | 2003-03-24 | 2004-09-25 | Osvaldo Legnini | Composizione alimentare, pasta alimentare funzionale |
| KR100520007B1 (ko) * | 2003-05-19 | 2005-10-11 | 건 식 조 | 혈압 강하 기능을 가지는 키토산 함유 소금의 제조방법 |
| WO2005089731A2 (en) * | 2004-03-17 | 2005-09-29 | Novartis Ag | Use of renin inhibitors in therapy |
| CN1692782A (zh) | 2005-06-26 | 2005-11-09 | 苟春虎 | 降压好酸奶片 |
| RU2290185C1 (ru) | 2005-07-26 | 2006-12-27 | Дмитрий Николаевич Мясников | Композиция для нормализации липидного обмена и снижения массы тела и способ её получения |
-
2006
- 2006-03-03 IT IT000384A patent/ITMI20060384A1/it unknown
-
2007
- 2007-03-02 PL PL07726617T patent/PL1996207T3/pl unknown
- 2007-03-02 WO PCT/EP2007/052023 patent/WO2007099170A1/en not_active Ceased
- 2007-03-02 MX MX2008011289A patent/MX2008011289A/es active IP Right Grant
- 2007-03-02 US US12/281,615 patent/US9050356B2/en active Active
- 2007-03-02 JP JP2008557733A patent/JP5557451B2/ja active Active
- 2007-03-02 ES ES07726617T patent/ES2392551T3/es active Active
- 2007-03-02 EP EP07726617A patent/EP1996207B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA78693C2 (en) | Use of eicosapentaenoic acid ethyl ester and docosahexaenoic acid ethyl ester for treating heart failure | |
| JP2017525771A (ja) | 体重と体脂肪減少に用いられる組成物およびその医薬品と使用 | |
| CN106659729A (zh) | 烟酰胺单核苷酸在制备防治动脉硬化、心脑血管疾病的药物中的应用及其药物 | |
| JP5846350B2 (ja) | 骨疾患予防又は治療用組成物 | |
| JP6161438B2 (ja) | 脂肪蓄積抑制及び／又は脂肪蓄積量低減剤 | |
| JP7206223B2 (ja) | パーキンソン病の予防および／または支持治療処置のための物質 | |
| JP5961034B2 (ja) | 安定化方法 | |
| JP2009531306A5 (enExample) | ||
| JP4355967B2 (ja) | 医薬組成物 | |
| JP6832113B2 (ja) | 医薬組成物 | |
| JP6771274B2 (ja) | 内服用組成物 | |
| JP2020515552A (ja) | 体重と体脂肪減少に用いられる組成物又は医薬品及びその用途 | |
| JP2010168399A (ja) | 血糖の上昇を抑制するための薬剤 | |
| JP5576621B2 (ja) | 内服用体臭抑制剤 | |
| JP5164407B2 (ja) | 末梢循環改善薬 | |
| JP2003095968A (ja) | 循環器疾患予防用組成物 | |
| WO2002034261A1 (en) | Compositions for improving lipids in blood | |
| JP4896531B2 (ja) | 血中ＣｏＱ１０量を増加させる医薬組成物 | |
| JP5452042B2 (ja) | 医薬組成物 | |
| JP2007031302A (ja) | アディポネクチン産生促進剤、及び代謝異常症候群予防剤 | |
| JP2009084207A (ja) | 医薬組成物 | |
| JP6539826B2 (ja) | コエンザイムｑ１０含有固形組成物 | |
| JP2021187858A (ja) | 医薬製剤 | |
| JP2009179592A (ja) | Ｑｏｌ改善剤 | |
| CN101897967A (zh) | 一种治疗血脂异常的沙棘黄酮复方制剂 |